Purpose
This study investigates the feasibility and potential benefits of radiotherapy with a 1.5 T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients.

Material and methods
Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (∼7 mm) or reduced (∼3 mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose–volume metrics or by quantifying dose escalation potential.

Results
All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation.

Conclusion
It is feasible to generate treatment plans for LA NSCLC patients on a 1.5 T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.